Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Clinical trial NCT06016855 · RECRUITING

Trial details

NCT number: NCT06016855
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Digestive System Neuroendocrine Tumor G1 Digestive System Neuroendocrine Tumor G2 Metastatic Digestive System Neuroendocrine Neoplasm Metastatic Malignant Neoplasm in the Liver Pancreatic Neuroendocrine Tumor G1 Pancreatic Neuroendocrine Tumor G2

Start date: 2024-05-31
Primary completion: 2027-05-28
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.